ロード中...

P-Glycoprotein Inhibition Sensitizes Human Breast Cancer Cells to Proteasome Inhibitors

Although effective for the treatment of hematological malignancies, the FDA approved proteasome inhibitors bortezomib and carfilzomib have limited efficacy in solid tumors including triple negative breast cancer (TNBC). Chemotherapy is the only option for treating TNBC due to the absence of specific...

詳細記述

保存先:
書誌詳細
出版年:J Cell Biochem
主要な著者: Deshmukh, Rahul R., Kim, Seongho, Elghoul, Yasmine, Dou, Q. Ping
フォーマット: Artigo
言語:Inglês
出版事項: 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6858998/
https://ncbi.nlm.nih.gov/pubmed/27813130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcb.25783
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!